Edition:
United States

Sarepta Therapeutics Inc (SRPT.OQ)

SRPT.OQ on NASDAQ Stock Exchange Global Select Market

153.09USD
3:57pm EDT
Change (% chg)

$0.74 (+0.49%)
Prev Close
$152.35
Open
$153.02
Day's High
$155.53
Day's Low
$150.32
Volume
234,998
Avg. Vol
437,175
52-wk High
$176.44
52-wk Low
$42.97

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 73.53 -1.669
Mar '18 64.60 -0.547
FY 2017 Dec '17 57.28 -0.376
Sep '17 45.95 -0.776
Jun '17 35.01 -1.147
Mar '17 16.34 1.501
FY 2016 Dec '16 5.42 -1.618
Sep '16 0.00 -1.176
Jun '16 0.00 -1.350
Mar '16 0.00 -1.308
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 18 78.65 81.00 76.60 78.64
Quarter Ending Dec-18 18 85.45 91.52 80.67 90.72
Year Ending Dec-18 20 302.19 308.97 296.80 273.13
Year Ending Dec-19 21 432.42 530.77 368.60 416.65
Earnings (per share)
Quarter Ending Sep-18 17 -0.81 -0.34 -1.70 -0.17
Quarter Ending Dec-18 17 -0.65 -0.24 -1.81 -0.04
Year Ending Dec-18 18 -3.69 -2.75 -5.75 -1.76
Year Ending Dec-19 19 -1.91 0.69 -5.36 -0.12
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 103.50 32.14
P/E High - Last 5 Yrs. -- 275.43 47.40
P/E Low - Last 5 Yrs. -- 97.43 24.78
Beta 1.13 0.62 0.87
Price to Sales (TTM) 41.94 109.71 6.23
Price to Book (MRQ) 14.46 12.03 3.80
Price to Tangible Book (MRQ) 14.79 18.41 5.78
Price to Cash Flow (TTM) -- 59.58 22.50
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.73
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.55 -5.60
Payout Ratio(TTM) -- 5.86 46.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 110.02 174.85 8.41
Sales (TTM) vs TTM 1 Yr. Ago 325.13 91.86 6.69
Sales - 5 Yr. Growth Rate 32.87 24.26 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago -45.50 272.94 25.39
EPS (TTM) vs TTM 1 Yr. Ago -38.05 -- --
EPS - 5 Yr. Growth Rate -- 23.39 7.57
Capital Spending - 5 Yr. Growth Rate 79.29 38.46 8.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 9.89 1.61 2.18
Current Ratio (MRQ) 10.88 5.48 2.95
LT Debt to Equity (MRQ) 61.50 14.97 11.33
Total Debt to Equity (MRQ) 62.86 18.40 14.17
Interest Coverage (TTM) -- -204.17 34.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 92.15 55.80 54.77
Gross Margin - 5 Yr. Avg. -- 52.46 53.26
EBITD Margin (TTM) -69.53 -- --
EBITD - 5 Yr. Avg -447.79 -175.51 15.90
Operating Margin (TTM) -84.20 -608.67 3.68
Operating Margin - 5 Yr. Avg. -476.49 -189.07 11.01
Pre-Tax Margin (TTM) -89.26 -605.68 3.97
Pre-Tax Margin - 5 Yr. Avg. -423.08 -191.53 11.18
Net Profit Margin (TTM) -89.64 -601.23 0.71
Net Profit Margin - 5 Yr. Avg. -424.20 -189.32 7.52
Effective Tax Rate (TTM) -- 11.41 20.36
Effective Tax Rate - 5 Yr. Avg. -- 18.93 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 946,526 5,162,908 710,435,462
Net Income/Employee (TTM) -848,478 -6,026,407 81,903,466
Receivable Turnover (TTM) 7.94 5.43 5.02
Inventory Turnover (TTM) 0.26 2.04 3.62
Asset Turnover (TTM) 0.28 0.37 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -25.49 0.74 9.68
Return on Assets - 5 Yr. Avg. -38.50 2.54 10.88
Return on Investment (TTM) -28.34 1.52 12.66
Return on Investment - 5 Yr. Avg. -44.98 2.08 14.01
Return on Equity (TTM) -40.19 0.25 14.84
Return on Equity - 5 Yr. Avg. -53.15 -1.25 15.40
  1 Year 3 Year 5 Year
Sales % 2,751.58 151.16 32.87
EPS (TTM) % 84.30 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Sarepta Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 19.37 18.06 99 95
13 Week 44.76 39.00 99 72
26 Week 93.39 81.61 99 44
52 Week 227.56 183.50 99 88
YTD 173.81 153.42 99 84
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 91.14%
# of Holders: 412
Total Shares Held: 60,554,645
3 Mo. Net Change: 3,347,854
# New Positions: 85
# Closed Positions: 53
# Increased Positions: 182
# Reduced Positions: 211
# Net Buyers: -29
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.